Tricuspid regurgitation following pacemaker implantation for bradycardia:a two-year study comparing different pacing strategies  

作　　者：Xiaofei Li Xiaohan Fan Qian Wang Zhao Wang Haojie Zhu Hui Li Hao Wang Zhimin Liu Yan Yao 

机构地区：[1]Department of Cardiology,Fuwai Hospital,National Center for Cardiovascular Diseases,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100037,China [2]Department of Echocardiography,Fuwai Hospital,National Center for Cardiovascular Diseases,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100037,China

出　　处：《Chinese Medical Journal》2023年第20期2508-2510,共3页中华医学杂志（英文版）

基　　金：supported by grants from the National Natural Science Foundation of China to Xiaohan Fan(No.81970284);the project for the Distinguishing Academic Discipline of Fuwai Hospital(No.2022-FWQN16)to Xiaofei Li.

摘　　要：To the Editor:Tricuspid regurgitation(TR)is a known complication of cardiac implantable electrical device(CIED)implantation with a prevalence of up to 10–30%.Due to the detrimental effects of right ventricular pacing(RVP)on cardiac function,His bundle pacing(HBP)and left bundle branch area pacing(LBBAP)have been increasingly used as physiological pacing modalities.This observational study aimed to assess the lead-related significant TR(moderate and severe)in patients with HBP,LBBAP,right ventricular apical pacing(RVAP),and right ventricular septal pacing(RVSP)in bradycardia patients during the two-year follow-up.

关 键 词：PACING VENTRICULAR CARDIA 

分 类 号：R541.72[医药卫生—心血管疾病]